期刊文献+

ALG/ATG治疗严重型再生障碍性贫血疗效机制研究进展 被引量:4

下载PDF
导出
摘要 抗淋巴细胞球蛋白(ALG)/抗胸腺细胞球蛋白(ATG)已广泛用于治疗严重型再生障碍性贫血(SAA),可使40%-70%患者获得缓解,其疗效机制复杂。目前研究表明ALG/ATG治疗SAA的可能作用机制为:①免疫抑制效应;②免疫刺激效应;③对造血干/粗细胞的直接刺激效应;④上述效应综合作用。
作者 郑以州
出处 《国外医学(内科学分册)》 1997年第5期206-208,共3页 Foreign Medical Sciences(Section of Internal Medicine)
  • 相关文献

同被引文献20

  • 1夏长青,储榆林.雄激素治疗再生障碍性贫血的现状[J].中华血液学杂志,1996,17(3):163-165. 被引量:14
  • 2邵宗鸿,储榆林,张益枝,陈桂彬,钱林生,杨天楹,杨崇礼,郝玉书.ALG、CsA并用GM-CSF、Epo治疗重型再生障碍性贫血初步观察[J].中华血液学杂志,1996,17(4):176-178. 被引量:41
  • 3于芳,唐锁勤,王建文.抗胸腺球蛋白/抗淋巴细胞球蛋白治疗重型再生障碍性贫血的疗效及其并发症[J].中国当代儿科杂志,2006,8(6):479-481. 被引量:10
  • 4储榆林.抗胸腺细胞球蛋白治疗23例再生障碍性贫血的临床研究[J].中华血液学杂志,1986,7(4):98-98. 被引量:5
  • 5MARSH J, SCHREZENMEIER H, MARIN P, et al. Prospective randomized multicenter study comparing cyclosporine alone versus the combination of antithy- mocyte globulin and cyclosporine for treatment of pa- tients with nonsevere aplastic anemia: a report from the European blood and marrow transplant (EBMT) severe aplastie anemia working party [J]. Blood, 1999,93:2191- 2195. 被引量:1
  • 6CRUMP M,LARRATT L M,MAKI E,et al. Treat- ment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin and rescue of ATG failures with bone marrow transplantation[J]. AmJ Med,1992,92:596- 596. 被引量:1
  • 7MARSH J C W, HOW J M, BRYETT K A, et al. Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity [J]. Blood, 1987,70 : 1046- 1052. 被引量:1
  • 8FACON T, WALTER M P, FENAWX P, et al. Treatment of severe aplastic anemia with antilympho- cyte globulin and androgens: a report on 33 patients [J].Ann Hematol,1991,63:89-93. 被引量:1
  • 9TICHELLI A, BARGETZI M, SPECK B, et al. Re- peated treatment with horse antilymphoeyte globulin for severe aplastic anemia[J]. Br J Haematol, 1998, 100:393-400. 被引量:1
  • 10BONA E D. RODEGHIERO F, BRUNO B, et al. Rabbit antithymocyte globulin (r- ATG) plus cyclos-porine and granulocyte colony stimulating factor is an effective treatment for aplastic anemia patients unre- sponsive to a first course of intertsive itnmunosuppres- sive therapy[J]. Br J Haematol, 1999, 107: 330- 334. 被引量:1

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部